RXST Key Statistics, Chart & Performance
The current stock price of RXST is 9.79 USD. In the past month the price decreased by -23.28%. In the past year, price decreased by -67.79%.
RXST Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to RXST. When comparing the yearly performance of all stocks, RXST is a bad performer in the overall market: 87.86% of all stocks are doing better.
RXST Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RXST. The financial health of RXST is average, but there are quite some concerns on its profitability.
RXST Financial Highlights
Over the last trailing twelve months RXST reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS decreased by -6.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.58% | ||
| ROE | -12.95% | ||
| Debt/Equity | 0 |
RXST Forecast & Estimates
16 analysts have analysed RXST and the average price target is 10.54 USD. This implies a price increase of 7.66% is expected in the next year compared to the current price of 9.79.
For the next year, analysts expect an EPS growth of -51.02% and a revenue growth -7.7% for RXST
RXST Ownership
RXST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 19.93 | 16.36B | ||
| SOLV | SOLVENTUM CORP | 13.54 | 13.95B | ||
| ALGN | ALIGN TECHNOLOGY INC | 17.73 | 12.30B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 21.6 | 4.76B | ||
| LNTH | LANTHEUS HOLDINGS INC | 10.98 | 4.34B | ||
| ICUI | ICU MEDICAL INC | 19.49 | 3.83B | ||
| HAE | HAEMONETICS CORP/MASS | 15.42 | 3.46B | ||
| XRAY | DENTSPLY SIRONA INC | 7.96 | 2.51B | ||
| NEOG | NEOGEN CORP | 32.62 | 2.06B | ||
| UFPT | UFP TECHNOLOGIES INC | 29.82 | 1.98B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.04B | ||
| EMBC | EMBECTA CORP | 4.24 | 737.23M |
Related stock screener links
About RXST
Company Profile
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 498 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Company Info
RXSIGHT INC
100 Columbia Street, Suite 120
Aliso Viejo CALIFORNIA US
CEO: Ron Kurtz
Employees: 498
Phone: 19495217822
RXSIGHT INC / RXST FAQ
What does RXSIGHT INC do?
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 498 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
What is the current price of RXST stock?
The current stock price of RXST is 9.79 USD. The price increased by 1.24% in the last trading session.
What is the dividend status of RXSIGHT INC?
RXST does not pay a dividend.
What is the ChartMill technical and fundamental rating of RXST stock?
RXST has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the expected growth for RXST stock?
The Revenue of RXSIGHT INC (RXST) is expected to decline by -7.7% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for RXSIGHT INC?
RXSIGHT INC (RXST) has a market capitalization of 402.56M USD. This makes RXST a Small Cap stock.
What is the Short Interest ratio of RXSIGHT INC (RXST) stock?
The outstanding short interest for RXSIGHT INC (RXST) is 11.47% of its float.